
| 2011 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2010 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2008 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2011 | 0 | 4.976.094 | 123.448 | 1 | ||
| 2010 | 0 | 17.982.600 | 1.527.674 | 2 | ||
Total number of partners: 43
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 43
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2011-03-01 | European Training Network on (+)RNA Virus Replication and Antiviral Drug Development | EUVIRNA | participant | 4.976.094 | 12 |
| 2010-10-01 | Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses | SILVER | participant | 12.000.000 | 24 |
| 2010-10-01 | Development of novel antiviral drugs against Influenza | FLUCURE | participant | 5.982.600 | 10 |